Merck's Oral COVID Treatment Yields Promising Trial Data
[unable to retrieve full-text content]
German pharmaceutical giant Merck and a US partner reported promising results Saturday in trials of a drug administered orally to fight COVID-19, saying it helps reduce patients' viral load.
Advertising by Adpathway




